ELMD vs. CBLL, RXST, BFLY, AVNS, EMBC, DCTH, BVS, KIDS, AXGN, and NPCE
Should you be buying Electromed stock or one of its competitors? The main competitors of Electromed include CeriBell (CBLL), RxSight (RXST), Butterfly Network (BFLY), Avanos Medical (AVNS), Embecta (EMBC), Delcath Systems (DCTH), Bioventus (BVS), OrthoPediatrics (KIDS), AxoGen (AXGN), and NeuroPace (NPCE). These companies are all part of the "medical equipment" industry.
Electromed vs. Its Competitors
Electromed (NYSE:ELMD) and CeriBell (NASDAQ:CBLL) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, profitability, dividends, community ranking, institutional ownership, valuation, analyst recommendations, risk and media sentiment.
Electromed presently has a consensus target price of $38.00, indicating a potential upside of 89.34%. CeriBell has a consensus target price of $32.50, indicating a potential upside of 88.19%. Given Electromed's stronger consensus rating and higher probable upside, equities research analysts clearly believe Electromed is more favorable than CeriBell.
40.8% of Electromed shares are owned by institutional investors. 14.0% of Electromed shares are owned by company insiders. Comparatively, 20.1% of CeriBell shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Electromed has a net margin of 11.34% compared to CeriBell's net margin of 0.00%. Electromed's return on equity of 15.71% beat CeriBell's return on equity.
In the previous week, CeriBell had 1 more articles in the media than Electromed. MarketBeat recorded 3 mentions for CeriBell and 2 mentions for Electromed. CeriBell's average media sentiment score of 1.46 beat Electromed's score of 0.00 indicating that CeriBell is being referred to more favorably in the news media.
Electromed received 15 more outperform votes than CeriBell when rated by MarketBeat users. However, 100.00% of users gave CeriBell an outperform vote while only 92.59% of users gave Electromed an outperform vote.
Electromed has higher earnings, but lower revenue than CeriBell.
Summary
Electromed beats CeriBell on 8 of the 15 factors compared between the two stocks.
Get Electromed News Delivered to You Automatically
Sign up to receive the latest news and ratings for ELMD and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding ELMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Electromed Competitors List
Related Companies and Tools
This page (NYSE:ELMD) was last updated on 6/13/2025 by MarketBeat.com Staff
Buy ELMD Stock Free ELMD Stock Alerts